|
WO2016028891A1
|
|
ORAL TRANSMUCOSAL COMPOSITIONS INCLUDING C-SERMs FOR LOW TESTOSTERONE LEVELS IN MEN
|
|
WO2016028900A1
|
|
Oral transmucosal pharmaceutical compositions including testosterone and an aromatase inhibitor
|
|
WO2016011340A1
|
|
Method for validation of pharmaceutical composition formulations
|
|
WO2015168224A1
|
|
Synergistic mixture of betamethasone and tranilast with a transdermal gel for scar treatment
|
|
WO2015134822A1
|
|
Poloxamer-based pharmaceutical compositions for treating wounds
|
|
WO2015031413A2
|
|
Transdermal delivery of anastrozole for systemic effect
|
|
WO2015031412A1
|
|
Testosterone booster transdermal compositions
|
|
WO2014205159A1
|
|
Poloxamer based inhalation composition
|
|
WO2014205157A1
|
|
Inhalation composition for treating respiratory tract infections
|
|
WO2014201450A1
|
|
Testosterone combined with anastrozole injection solutions
|
|
WO2014201083A2
|
|
Phenoxybenzamine transdermal composition
|
|
WO2014190179A2
|
|
Urea silicon gel for scars and hydration treatment and method of using same
|
|
WO2014190182A1
|
|
Topical scar treatment composition and method of using same
|
|
US2014348780A1
|
|
Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
|
